Company / Free Cash Flow per Share
Neurogene Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4.81
FY2025
5-year range
-$4.81 / -$1.32
FY2021-FY2025
Trend
-19.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has declined for 3 consecutive years, from $-1.32 in FY2018 to $-4.81 in FY2025.
Based on SEC 10-K filings.
-4.81 in FY2025.
Declined from $-1.92 to $-4.81 over the past 6 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Neurogene Inc.'s free cash flow per share has declined for 3 consecutive years.
- In FY2025, free cash flow per share decreased 19.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.81 | -19.1% |
| FY2024 | -$4.03 | -110.1% |
| FY2019 | -$1.92 | -45.7% |
| FY2018 | -$1.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026